Therefore, depletion of IDO inhibits tumor stem cells proliferation pathways and improves immunotherapeutic vaccines susceptibility by reducing TLRs 2 to 9, NF-κβ1-2, Wnt/β-catenin and TGF-β (163). The gene discussed is TGFB1; the disease is neoplasm.